JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$1.09B |
| 2 |
Broadcom
AVGO
|
+$1.03B |
| 3 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$970M |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
+$877M |
| 5 |
Verizon
VZ
|
+$875M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.58B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.37B |
| 3 |
TWX
Time Warner Inc
TWX
|
+$764M |
| 4 |
IBM
IBM
|
+$737M |
| 5 |
Philip Morris
PM
|
+$640M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.15% |
| 2 | Financials | 14% |
| 3 | Technology | 12.71% |
| 4 | Healthcare | 9.7% |
| 5 | Consumer Discretionary | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2801
FerroAtlántica
GSM
$796M
| $3.72M | ﹤0.01% |
433,691
+395,653
| +1,040% | +$4.15M |
2016 Q4
6 quarters
|
|
2802
Caesarstone
CSTE
$99.2M
| $3.71M | ﹤0.01% |
245,672
+204,978
| +504% | +$3.51M |
2013 Q2
20 quarters
|
|
|
GRP.U
2803
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $3.71M | ﹤0.01% |
90,925
-116,348
| -56% | -$4.69M |
2015 Q4
10 quarters
|
|
|
BPFH
2804
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $3.7M | ﹤0.01% |
232,967
+23,766
| +11% | +$391K |
2013 Q2
20 quarters
|
|
2805
Unitil
UTL
$934M
| $3.7M | ﹤0.01% |
72,408
-54,169
| -43% | -$2.61M |
2013 Q2
20 quarters
|
|
|
FLXN
2806
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $3.69M | ﹤0.01% |
142,895
-8,502
| -6% | -$221K |
2015 Q4
10 quarters
|
|
|
SYRS
2807
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $3.69M | ﹤0.01% |
36,167
-1,284
| -3% | -$159K |
2016 Q3
7 quarters
|
|
2808
CALL
Bath & Body Works
BBWI
$3.24B
| $3.69M | ﹤0.01% |
123,700
-30,925
| -20% | -$893K |
2017 Q1
5 quarters
|
|
2809
Urban Edge Properties
UE
$2.49B
| $3.68M | ﹤0.01% |
160,875
+64,737
| +67% | +$1.38M |
2015 Q3
11 quarters
|
|
2810
Aclaris Therapeutics
ACRS
$646M
| $3.67M | ﹤0.01% |
184,029
-6,252
| -3% | -$116K |
2017 Q4
2 quarters
|
|
|
AIMT
2811
DELISTED
Aimmune Therapeutics
AIMT
| $3.67M | ﹤0.01% |
136,677
-6,074
| -4% | -$186K |
2016 Q1
9 quarters
|
|
2812
Schwab International Equity ETF
SCHF
$68B
| $3.67M | ﹤0.01% |
221,996
+56,804
| +34% | +$965K |
2014 Q2
16 quarters
|
|
2813
NMI Holdings
NMIH
$2.92B
| $3.67M | ﹤0.01% |
224,926
-171,283
| -43% | -$2.77M |
2013 Q4
18 quarters
|
|
|
SYNH
2814
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $3.67M | ﹤0.01% |
78,121
-474
| -0.6% | -$19.6K |
2015 Q4
10 quarters
|
|
|
FTSV
2815
DELISTED
Forty Seven, Inc. Common Stock
FTSV
| $3.66M | ﹤0.01% |
+228,924
| New | +$3.55M |
2018 Q2
0 quarters
|
|
2816
VanEck Morningstar Wide Moat ETF
MOAT
$11.3B
| $3.66M | ﹤0.01% |
83,987
+5,944
| +8% | +$253K |
2017 Q2
4 quarters
|
|
|
LHCG
2817
DELISTED
LHC Group LLC
LHCG
| $3.65M | ﹤0.01% |
42,695
-89,879
| -68% | -$6.85M |
2016 Q2
8 quarters
|
|
2818
Rogers Corp
ROG
$2.86B
| $3.65M | ﹤0.01% |
32,723
-13,505
| -29% | -$1.58M |
2016 Q2
8 quarters
|
|
2819
Open Text
OTEX
$5.38B
| $3.65M | ﹤0.01% |
103,587
+3,410
| +3% | +$120K |
2015 Q4
10 quarters
|
|
2820
ONE Gas
OGS
$4.56B
| $3.63M | ﹤0.01% |
48,617
-114,347
| -70% | -$8.13M |
2015 Q4
10 quarters
|
|
2821
CALL
PACCAR
PCAR
$57.7B
| $3.63M | ﹤0.01% |
87,900
| – | – |
2017 Q4
2 quarters
|
|
|
2822
PUT
PACCAR
PCAR
$57.7B
| $3.63M | ﹤0.01% |
87,900
| – | – |
2017 Q4
2 quarters
|
|
2823
Resources Connection
RGP
$134M
| $3.63M | ﹤0.01% |
214,863
-3,147
| -1% | -$51.5K |
2013 Q2
20 quarters
|
|
2824
PUT
Warner Bros
WBD
$77.6B
| $3.63M | ﹤0.01% |
+131,900
| New | +$3.14M |
2018 Q2
0 quarters
|
|
2825
Barron's 400 ETF
BFOR
$232M
| $3.62M | ﹤0.01% |
334,808
+23,572
| +8% | +$252K |
2017 Q4
2 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2018 Portfolio in Review
As of Q2 2018, JP Morgan Chase held 5,918 positions worth $486B, up 4.2% from $467B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2018 filing shows 539 new, 2,430 increased, 2,080 reduced and 346 closed positions. Its largest new stake was Evergy: 3,598,208 shares worth $202M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.58B.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, up from 23% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q2 2018 buy was Evergy: 3,598,208 shares worth $202M.
- JP Morgan Chase added most to Salesforce in Q2 2018, an estimated $1.09B increase.
- JP Morgan Chase's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.58B.
- JP Morgan Chase fully exited Time Warner Inc in Q2 2018, selling an estimated $764M.
- JP Morgan Chase's ten largest holdings make up 17% of its $486B portfolio in Q2 2018.
- JP Morgan Chase opened 539 new positions and closed 346 in Q2 2018.
- JP Morgan Chase's portfolio value rose 4.2% quarter-over-quarter to $486B.
Based on JP Morgan Chase's 13F filing for Q2 2018, filed 14 Aug 2018.